Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
One complicating factor is manufacturer rebates, which are discounts on prescription list prices provided by drug manufacturers to pharmacy benefit managers, which in turn may share some or all of ...
The Dean of the Faculty of Renewable Natural Resources, University of Ibadan, Professor Adejoke Akinyele, has called on the federal government to eliminate the activities of middlemen in the food ...
Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections in the U ...
The trial results come less than two months after the U.S. Food and Drug Administration rejected Novo Nordisk's application for approval of a once-weekly basal insulin for diabetes patients.
the drug companies claim that they ultimately have to raise list prices in order to pay the middlemen.
The overall safety of insulin efsitora was similar to that of daily basal insulin therapies. Topline data were announced from 2 studies in the QWINT phase 3 clinical development program ...
Scientists from China have investigated how short peptide chains aggregate together in order to deepen our understanding of the process which is crucial for drug stability and material development.
US drug authorities are allowing 24% more production of Vyvanse, an ADHD drug from Takeda Pharmaceutical Co. and generic rivals, to address treatment shortages that have dragged on for the past ...
South Africans need to be in the know if we want to create a prosperous future. News24 has kept the country informed for 25 years, and we're about to enter a new chapter of fearless journalism. Join ...
South Africans need to be in the know if we want to create a prosperous future. News24 has kept the country informed for 25 years, and we're about to enter a new chapter of fearless journalism. Join ...